Figure 2

Abdominal precontrast magnetic resonance imaging (MRI) show lesions in segment II. Most of the tumor in segment II has heterogeneously high signal intensity on both fat suppressed T2-weighted images (A, white arrow) and T1-weighted images (B, white arrow). On delayed-phase images after gadopentetate dimeglumine administration, central delayed enhancement was noted in all three tumors (C and D, white arrowheads).